Cargando…

PB1912: MYELODYSPLASTIC SYNDROME WITH ISOLATED 5Q DELETION AND ASSOCIATED 5Q DELETION TO 13Q DELETION

Detalles Bibliográficos
Autores principales:	Bouayed Abdelmoula, N., Abdelmoula, B., Karra, A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Publication Only
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431497/ http://dx.doi.org/10.1097/01.HS9.0000850500.71717.8d

Ejemplares similares

PB1997: TRISOMY 18 IN MYELODYSPLASTIC SYNDROMES
por: Abdelmoula, Nouha Bouayed, et al.
Publicado: (2023)

PB2169: LENALIDOMIDE, BORTEZOMIB AND DEXAMETHASONE COMBINATION THERAPY IN CONCOMITANT MYELODYSPLASTIC SYNDROME WITH ISOLATED 5Q DELETION AND MULTIPLE MYELOMA
por: Koh, Yu Han, et al.
Publicado: (2023)

PB1891: VARIANT PHILADELPHIA CHROMOSOME IN CML
por: Bouayed Abdelmoula, N., et al.
Publicado: (2022)

PB1757: VARIANT PHILADELPHIA CHROMOSOME IN ALL
por: Bouayed Abdelmoula, N., et al.
Publicado: (2022)

PB2669: PCR‐RFLP ASSAY FOR THE DETECTION OF THROMBOPHILIC GENE POLYMORPHISMS
por: Abdelmoula, Nouha Bouayed
Publicado: (2023)

5q Deletion Myelodysplastic Syndrome in a Young Male Patient
por: Elkattawy, Sherif, et al.
Publicado: (2021)

Part 4: Myelodysplastic syndromes—Treatment of low-risk patients with the 5q deletion
por: Magalhães, Silvia Maria Meira, et al.
Publicado: (2018)

Routes of Clonal Evolution into Complex Karyotypes in Myelodysplastic Syndrome Patients with 5q Deletion
por: Feurstein, Simone, et al.
Publicado: (2018)

Deletion 22q13.3 syndrome
por: Phelan, Mary C
Publicado: (2008)

Chromosome 11q13 deletion syndrome
por: Kim, Yu-Seon, et al.
Publicado: (2016)

PB1913: SYNERGISTIC EFFECTS OF DECITABINE AND APR-246 IN TP53 P.248Q-MUTATED MYELODYSPLASTIC SYNDROME
por: Fang, Y., et al.
Publicado: (2022)

Outcome of patients treated for myelodysplastic syndromes with 5q deletion after failure of lenalidomide therapy
por: Prebet, Thomas, et al.
Publicado: (2017)

Part 3: Myelodysplastic syndromes—Treatment of low-risk patients without the 5q deletion
por: Velloso, Elvira Deolinda Rodrigues Pereira, et al.
Publicado: (2018)

Myelodysplastic Syndromes with Isolated 20q Deletion: A New Clinical–Biological Entity?
por: Campagna, Alessia, et al.
Publicado: (2022)

A Case of Refractory Thrombocytopenia with 5q Deletion: Myelodysplastic Syndrome Mimicking Idiopathic Thrombocytopenic Purpura
por: Chang, Jeonghyun, et al.
Publicado: (2014)

Analysis of the efficacy of lenalidomide in patients with intermediate-1 risk myelodysplastic syndrome without 5q deletion
por: YANG, YAN, et al.
Publicado: (2013)

Outcome of patients treated for myelodysplastic syndromes without deletion 5q after failure of lenalidomide therapy
por: Prebet, Thomas, et al.
Publicado: (2017)

Lenalidomide Plus Decitabine Treatment in a Myelodysplastic Syndrome Patient With Deletion 5q and Excess Blasts
por: Serin, Istemi, et al.
Publicado: (2020)

Terminal 4q Deletion Syndrome
por: Kuldeep, C M, et al.
Publicado: (2012)

Chromosome 13q deletion syndrome involving 13q31-qter: A case report
por: Wang, Yue-Ping, et al.
Publicado: (2017)

A child with mosaicism for deletion (14)(q11.2q13)
por: Gamage, Thilini H., et al.
Publicado: (2012)

The Role of Real-World Evidence in UK Reimbursement: Case Study of Lenalidomide in Myelodysplastic Syndrome Deletion 5q
por: Lee, Dawn, et al.
Publicado: (2018)

Lenalidomide treatment of Japanese patients with myelodysplastic syndromes with 5q deletion: a post-marketing surveillance study
por: Uno, Shuji, et al.
Publicado: (2023)

Expanding the Clinical Phenotype of 19q Interstitial Deletions: A New Case with 19q13.32-q13.33 Deletion and Short Review of the Literature
por: Shelby, Elena-Silvia, et al.
Publicado: (2022)

Genome-wide DNA methylation analysis pre- and post-lenalidomide treatment in patients with myelodysplastic syndrome with isolated deletion (5q)
por: Hecht, Anna, et al.
Publicado: (2021)

Acquired Elliptocytosis as a Manifestation of Myelodysplastic Syndrome Associated with Deletion of Chromosome 20q
por: Manthri, Sukesh, et al.
Publicado: (2018)

Atypical 15q11.2-q13 Deletions and the Prader-Willi Phenotype
por: Grootjen, Lionne N., et al.
Publicado: (2022)

Myeloid leukemia with t(7;21)(p22;q22) and 5q deletion
por: PANAGOPOULOS, IOANNIS, et al.
Publicado: (2013)

PB1815: ADDITIONAL СYTOGENETIC ABNORMALITIES IN ADULT ACUTE MYELOID LEUKEMIA WITH T(8;21)(Q22;Q22)
por: Zotova, Olena, et al.
Publicado: (2023)

Isolated Chromosome 6q27 Terminal Deletion Syndrome
por: Bhatta, Sabita, et al.
Publicado: (2020)

Phenotypical characterization of 13q deletion syndrome: Report of two cases
por: Bagherizadeh, Eiman, et al.
Publicado: (2014)

Deletion of 7q33-q35 in a Patient with Intellectual Disability and Dysmorphic Features: Further Characterization of 7q Interstitial Deletion Syndrome
por: Dilzell, Kristen, et al.
Publicado: (2015)

Adult Height, 22q11.2 Deletion Extent, and Short Stature in 22q11.2 Deletion Syndrome
por: Heung, Tracy, et al.
Publicado: (2022)

Small-cell lung cancer is characterized by a high incidence of deletions on chromosomes 3p, 4q, 5q, 10q, 13q and 17p.
por: Petersen, I., et al.
Publicado: (1997)

Van den Berghe's 5q- syndrome and myelodysplastic syndrome with isolated del(5q)
por: Lima, Diego Silva, et al.
Publicado: (2015)

Retinoblastoma and mosaic 13q deletion: a case report
por: Gargallo, Pablo, et al.
Publicado: (2021)

An Interstitial Deletion at 10q26.2q26.3
por: Iourov, Ivan Y., et al.
Publicado: (2014)

Features of Two Cases with 18q Deletion Syndrome
por: Özsu, Elif, et al.
Publicado: (2014)

22q11 deletion syndrome: current perspective
por: Hacıhamdioğlu, Bülent, et al.
Publicado: (2015)

22q11 Deletion Syndrome with Vascular Anomalies
por: Maldjian, Pierre, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_br52jps86o7m9hdn0s16cd762d